A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protection.

ABSTRACT: Radiotherapy is the current frontline cancer treatment, but the resulting severe side effects often pose a significant threat to cancer patients, raising a pressing need for the development of effective strategies for radiotherapy protection. We exploited the distinct metabolic characteristics between normal and malignant cells for a metabolic mechanism of normal tissue protection. We showed that low doses of arsenic induce HIF-1α, which activates a metabolic shift from oxidative phosphorylation to glycolysis, resulting in increased cellular resistance to radiation. Of importance is that low-dose arsenic-induced HIF-1α requires functional p53, limiting the glycolytic shift to normal cells. Using tumor-bearing mice, we provide proof of principle for selective normal tissue protection agains

SUBMITTER: Ganapathy S 

PROVIDER: S-EPMC3931089 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature